Polypeptides for engineering integrase chimeric proteins and their use in gene therapy
AssigneesInserm (Institut National De La Sante Et De La Recherche Medicale), Centre National De La Recherche Scietifique (Cnrs), Universite Paris Diderot—Paris 7, Commissariat A L'energie Atomique Et Aux Energies Alternatives, CNAM - Conservatoire National Des Arts Et Metiers
InventorsAntoine Bridier-Nahmias, Michel Werner, Pascale Lesage
Life of this patent
Estimating the term…
Abstract
The present invention relates to polypeptide for engineering integrase chimeric proteins and their use in gene therapy. In particular, the present invention relates to a polypeptide which comprises the amino acid sequence ranging from the amino acid residue at position 617 to the amino acid residue at position 622 in SEQ ID NO: 1 or a function conservative thereof.
Claims19
A polypeptide which comprises the amino acid sequence ranging from the amino acid residue at position 617 to the amino acid residue at position 622 in SEQ ID NO:1 or a function conservative thereof.
Dependencies are inferred from the claim text.